IPC
MYGN icon

Independent Portfolio Consultants’s Myriad Genetics MYGN Stock Holding History

Independent Portfolio Consultants’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-720
Closed -$27K – 791
2015
Q3 		$27K Sell
720
-85
-11% -$3.02K 0.01% 657
2015
Q2 		$27K Sell
805
-420
-34% -$14.3K 0.01% 689
2015
Q1 		$43K Sell
1,225
-255
-17% -$9.13K 0.01% 629
2014
Q4 		$50K Buy
1,480
+1,125
+317% +$39.9K 0.01% 633
2014
Q3 		$14K Sell
355
-470
-57% -$17.5K ﹤0.01% 721
2014
Q2 		$32K Buy
+825
New +$30.7K 0.01% 710

Other funds holding MYGN

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Independent Portfolio Consultants's MYGN Position: Q4 2015 in Review

Independent Portfolio Consultants sold out of Myriad Genetics (MYGN) in Q4 2015, closing a stake of 720 shares — an estimated $27K sold.

Independent Portfolio Consultants first reported a position in MYGN in Q2 2014 and held it in 6 quarters. The position peaked at $50K in Q4 2014. 232 funds tracked by Wall St. Rank hold MYGN as of Q4 2015.

  • Independent Portfolio Consultants reported no remaining Myriad Genetics position as of Q4 2015 after selling out during the quarter.
  • Independent Portfolio Consultants sold 720 Myriad Genetics shares in Q4 2015, an estimated $27K.
  • Independent Portfolio Consultants first reported a position in Myriad Genetics in Q2 2014 and held it in 6 quarters.
  • Independent Portfolio Consultants's Myriad Genetics position peaked at $50K in Q4 2014.
  • 232 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2015.

Based on Independent Portfolio Consultants's 13F filing for Q4 2015, filed 12 Jan 2016.